Clinical outcomes in non-small-cell lung cancer patients with EGFR mutations: pooled analysis
作者： Luis Paz-Ares , Denis Soulières , Ivan Melezínek , Joachim Moecks , Lorenz Keil
DOI: 10.1111/J.1582-4934.2009.00991.X
关键词:
摘要: … of space restrictions, only key or summary papers have been cited in this literature review. … mice with inducible expression of two common EGFR mutants seen in human lung cancer. …
researchgate.net 
sci-hub.se 参考文章(132)
Y Yarden, The EGFR family and its ligands in human cancer. signalling mechanisms and therapeutic opportunities. European Journal of Cancer. ,vol. 37, pp. 3- 8 ,(2001) , 10.1016/S0959-8049(01)00230-1
Anne S. Tsao, Xi Ming Tang, Bradley Sabloff, Lianchun Xiao, Hisayuki Shigematsu, Jack Roth, Margaret Spitz, Waun Ki Hong, Adi Gazdar, Ignacio Wistuba, Clinicopathologic Characteristics of the EGFR Gene Mutation in Non–small Cell Lung Cancer Journal of Thoracic Oncology. ,vol. 1, pp. 231- 239 ,(2006) , 10.1016/S1556-0864(15)31573-2
Spaventi S, Pavelic K, Banjac Z, Pavelic J, Evidence for a role of EGF receptor in the progression of human lung carcinoma Anticancer Research. ,vol. 13, pp. 1133- 1137 ,(1993)
D. M. Jackman, L. Cioffredi, N. I. Lindeman, L. K. Morse, J. Lucca, D. Weckstein, M. S. Huberman, T. J. Lynch, B. E. Johnson, P. A. Janne, Phase II trial of erlotinib in chemotherapy-naive women with advanced pulmonary adenocarcinoma Journal of Clinical Oncology. ,vol. 27, pp. 8065- 8065 ,(2009) , 10.1200/JCO.2009.27.15_SUPPL.8065
J. Hong, Y. Kim, S. Park, E. Cho, D. Shin, Epidermal growth factor-receptor mutations and the clinical outcome in male smokers with squamous cell carcinoma of lung Journal of Clinical Oncology. ,vol. 26, pp. 22136- 22136 ,(2008) , 10.1200/JCO.2008.26.15_SUPPL.22136
Y. Tambo, K. Kasahara, T. Sone, H. Kimura, A. Sakai, T. Araya, A. Ueda, M. Fujimura, S. Nakao, Prognostic and predictive impact of EGFR and K-ras mutation, and EGFR gene copy number in patients with advanced non-small cell lung cancer (NSCLC) who received first-line cytotoxic chemotherapy Journal of Clinical Oncology. ,vol. 27, pp. 8096- 8096 ,(2009) , 10.1200/JCO.2009.27.15_SUPPL.8096
Long-Yun Li, Xiao-Tong Zhang, Shu-Lan Wang, Meng-Zhao Wang, Xin-Lin Mu, Wei Song, Improvements in quality of life and disease-related symptoms in patients with advanced non-small cell lung cancer treated with gefitinib. Chinese Medical Journal. ,vol. 118, pp. 1661- 1664 ,(2005)
Allan R. Li, Dhananjay Chitale, Gregory J. Riely, William Pao, Vincent A. Miller, Maureen F. Zakowski, Valerie Rusch, Mark G. Kris, Marc Ladanyi, EGFR Mutations in Lung Adenocarcinomas: Clinical Testing Experience and Relationship to EGFR Gene Copy Number and Immunohistochemical Expression The Journal of Molecular Diagnostics. ,vol. 10, pp. 242- 248 ,(2008) , 10.2353/JMOLDX.2008.070178
Daniel B. Costa, Susan T. Schumer, Daniel G. Tenen, Susumu Kobayashi, Differential Responses to Erlotinib in Epidermal Growth Factor Receptor (EGFR)-Mutated Lung Cancers With Acquired Resistance to Gefitinib Carrying the L747S or T790M Secondary Mutations Journal of Clinical Oncology. ,vol. 26, pp. 1182- 1184 ,(2008) , 10.1200/JCO.2007.14.9039
Michael Ciesielski, Robert Fenstermaker, Structure of the Epidermal Growth Factor Receptor Gene and Intron Recombination in Human Gliomas Current Genomics. ,vol. 4, pp. 1- 12 ,(2003) , 10.2174/1389202033350092